APA (7th ed.) Citation

D, G., A, R., C, S., M, M., E, F., V, C., . . . S, E. (2024). Assessing the long-term prognostic ability of the 70 gene expression signature MammaPrint in an Italian single-center prospective cohort study of early-stage intermediate-risk breast cancer patients. Heliyon, 10(21), e39485. https://doi.org/10.1016/j.heliyon.2024.e39485

Chicago Style (17th ed.) Citation

D, Generali, et al. "Assessing the Long-term Prognostic Ability of the 70 Gene Expression Signature MammaPrint in an Italian Single-center Prospective Cohort Study of Early-stage Intermediate-risk Breast Cancer Patients." Heliyon 10, no. 21 (2024): e39485. https://doi.org/10.1016/j.heliyon.2024.e39485.

MLA (9th ed.) Citation

D, Generali, et al. "Assessing the Long-term Prognostic Ability of the 70 Gene Expression Signature MammaPrint in an Italian Single-center Prospective Cohort Study of Early-stage Intermediate-risk Breast Cancer Patients." Heliyon, vol. 10, no. 21, 2024, p. e39485, https://doi.org/10.1016/j.heliyon.2024.e39485.